The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Airway hyperreactivity in children with sickle cell disease
Abstract
Progressive restrictive defect with increasing age, obstructive lung disease, and bronchodilator responsiveness have been reported in sickle cell disease (SCD). Because airway hyperreactivity (AHR) can be underestimated when assessed by bronchodilator responsiveness in patients with normal baseline lung function, the aim of this study was to investigate the prevalence of AHR in SCD by cold-air bronchial provocation testing, and to assess whether AHR can be present in symptom-free patients with SCD. Forty patients aged 6 to 19 years (mean, 10.7 years +/- 3.5 SD) performed pulmonary function tests. Eighteen were known to have a history of reactive airway disease (RAD group), and 22 had no known history of RAD (non-RAD group). A control group, aged 6 to 7 years (mean, 10.5 +/- 3.1 years), consisted of 10 siblings of the non-RAD SCD group. There were no significant differences in age and height among the groups. If the forced expiratory volume in 1 second (FEV1) was greater than 70%, cold air challenge (CACh) was performed; if the FEV1 was less than 70%, aerosolized bronchodilator therapy was given. A decrease in FEV1 of more than 10% after CACh or an increase in FEV1 of 12% or greater after bronchodilator inhalation was considered evidence of AHR. In the RAD group, the total lung capacity was 88.9% +/- 14.0% of race-corrected predicted values, the forced vital capacity was 91.2% +/- 12.6%, and FEV1 was 85.3% +/- 16.2%. The mean maximal percent fall in FEV1 after CACh (n = 13) wa…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bronchial hyper-reactivity, asthma, and chronic airway inflammation (209) are highly prevalent in children with SCD and may result in a proinflammatory milieu that amplifies cellular and humoral immunity to airway pathogens, thus leading to a paroxysmal, detrimental response (210, 211).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [209]
Citations
Cites
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Knudson, R. J., Lebowitz, M. D., Holberg, C. J., & Burrows, B. A. (1983) · PubMed · doi:10.1164/arrd.1983.127.6.725 · Cited by 1,907
Lung Function Testing: Selectionof reference Values and Interpretative Strategies
Miller, A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.5_pt_1.1368b · Cited by 1,426
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.
Empey, D. W., Laitinen, L. A., Jacobs, L., Gold, W. M., & Nadel, J. A. (1976) · PubMed · doi:10.1164/arrd.1976.113.2.131 · Cited by 955
Castro, O., Brambilla, D., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J., & Levy, P. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 808
Castro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615
Causes of death in sickle-cell disease in Jamaica.
Thomas, A. N., Pattison, C., & Serjeant, G. R. (1982) · BMJ · doi:10.1136/bmj.285.6342.633 · Cited by 266
Bronchial hyperirritability in healthy subjects after exposure to ozone.
Golden, J. A., Nadel, J. A., & Boushey, H. A. (1978) · PubMed · doi:10.1164/arrd.1978.118.2.287 · Cited by 258
Deal, E. C., Er, M., Ingram, R. H., Breslin, F. J., & Jj, J. (1980) · PubMed · doi:10.1164/arrd.1980.121.4.621 · Cited by 200
Hsu, K. H. K., Jenkins, D. E., Hsi, B. P., Bourhofer, E., Thompson, V., Tanakawa, N., & Hsieh, G. S. J. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80075-x · Cited by 197
Research works printed but not linked: 5
- Nickerson, 1994, Pulmonary function in children with sickle cell disease, Am J Respir Crit Care Med, 149, A374
- Zar, 1994, Airway obstruction in children and young adults with sickle cell disease, Am J Respir Crit Care Med, 149, A374
- Weiss, 1984, Airways hyperresponsiveness in a population sample of adults and children, Am Rev Respir Dis, 129, 898
- Leong, 1994, Oxyhemoglobin desaturation in children with sickle cell disease, Am J Respir Crit Care Med, 149, A374
- Dampier, 1994, The presence of reactive airway disease predicts an increased risk for painful episodes in pediatric patients with sickle cell disease, Pediatr Res, 35, 160A
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
“Elevated arginase activity has also recently been discovered in asthma,(56-59) another T-cell type 2 cytokine–related disorder(60,61) that may be relevant to the pathophysiology of SCD since 30% to 70% of pediatric patients with SCD have reactive airways.(62,63) An association of arginase activity with plasma soluble…”
BackgroundDecreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma
Morris, C. R., Poljakovic, M., Lavrisha, L., Machado, L., Kuypers, F. A., & Morris, S. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1304oc · Cited by 283
“It is worth noting that asthma occurs in 30–70% of patients with sickle cell disease (60, 61), but is often unrecognized and untreated by clinicians.”
Lonergan, G. J., Cline, D. B., & Abbondanzo, S. L. (2001) · RadioGraphics · doi:10.1148/radiographics.21.4.g01jl23971 · Cited by 254
Metadata
- Authors
- Leong, M. A., Dampier, C., Varlotta, L., & Allen, J. L.
- Affiliations
- St. Christopher's Hospital for Children (US)
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1997-08
- Volume
- 131
- Issue
- 2
- Pages
- 278-283
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2043567553
- Cited by
- 140
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 11 · 2012: 4
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r01hl051493-06, 5r01hl051494-04, 7r01hl051495-06)
- National Heart, Lung, and Blood Institute (R01 HL-51493, R01 HL-51494, R01 HL-51495)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- sickle cell disease, airway hyperresponsiveness, cold air challenge, bronchodilator responsiveness, obstructive lung disease, reactive airway disease, children, lung function, FEV1, total lung capacity, forced vital capacity, siblings as controls, obstructive sleep apnea
- MeSH terms
- Administration, Inhalation, Adolescent, Adult, Aerosols, Age Factors, Air, Anemia, Sickle Cell, Body Height, Bronchial Provocation Tests, Bronchodilator Agents, Child, Cold Temperature, Female, Forced Expiratory Volume, Forecasting, Humans, Lung, Lung Diseases, Obstructive, Male, Maximal Midexpiratory Flow Rate, Residual Volume, Total Lung Capacity, Vital Capacity, Prevalence, Bronchial Hyperreactivity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Airway hyperreactivity in children with sickle cell disease. https://app.cochat.ai/papers/10.1016/s0022-3476(97)70166-5
- The paper
- Leong, M. A., Dampier, C., Varlotta, L., & Allen, J. L. (1997). Airway hyperreactivity in children with sickle cell disease. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(97)70166-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.